IMNM
Immunome Inc
NASDAQ · Biotechnology
$24.88
+0.88 (+3.67%)
Performance
1D
—
1W
-4.82%
1M
+20.95%
3M
+42.01%
6M
+148.55%
1Y
+121.75%
YTD
+19.50%
Open$24.61
Previous Close$24.00
Day High$25.76
Day Low$24.32
52W High$27.65
52W Low$5.15
Volume1.14M
Avg Volume1.46M
Market Cap2.75B
P/E Ratio—
EPS$-2.95
SectorBiotechnology
Volume Analysis
0.78x average volume
Technical Indicators
SMA 50
$21.81
Above
SMA 200
$13.75
Above
RSI (14)
60.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+428.5% upside
Current
$24.88
$24.88
Target
$131.49
$131.49
$82.08
$131.49 avg
$141.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.01M | 603.96M | 550.96M |
| Net Income | -551,235,025 | -173,219,826 | -162,867,502 |
| Profit Margin | -3,240.4% | -28.7% | -29.6% |
| EBITDA | -572,441,464 | -273,358,868 | -247,027,649 |
| Free Cash Flow | — | -130,399,233 | -192,377,550 |
| Rev Growth | — | +13.0% | +19.7% |
| Debt/Equity | — | 0.20 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |